Edwards Lifesciences (EW) Non-Current Debt (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Non-Current Debt of $598.5 million for Q1 2026, little changed year-over-year from $597.8 million in Q1 2025, and little changed quarter-over-quarter from $598.3 million in Q4 2025.
Edwards Lifesciences (EW) Non-Current Debt (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Non-Current Debt history runs 18 years deep, the most recent figure standing at $598.5 million for Q1 2026.
- In Q1 2026, Non-Current Debt changed 0.12% year-over-year to $598.5 million; the TTM figure through Mar 2026 stood at $598.5 million (changed 0.12% YoY), while the FY2025 annual figure was $598.3 million, changed 0.1% from the prior year.
- Non-Current Debt for Q1 2026 stood at $598.5 million, roughly flat from $598.3 million in the prior quarter.
- The five-year high for Non-Current Debt was $598.5 million in Q1 2026, with the low at $595.9 million in Q1 2022.
- The 5-year median for Non-Current Debt is $597.2 million (2024), against an average of $597.2 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt increased 0.12% in 2022, then increased 0.1% in 2025.
- Edwards Lifesciences' Non-Current Debt stood at $596.3 million in 2022, then grew by 0.12% to $597.0 million in 2023, then climbed by 0.12% to $597.7 million in 2024, then grew by 0.1% to $598.3 million in 2025, then rose by 0.03% to $598.5 million in 2026.
- Business Quant data shows EW's Non-Current Debt at $598.5 million in Q1 2026, $598.3 million in Q4 2025, and $598.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 598.70 Mn |
| Mar 31, 2026 | 598.50 Mn |
| Dec 31, 2025 | 598.30 Mn |
| Sep 30, 2025 | 598.20 Mn |
| Jun 30, 2025 | 598.00 Mn |
| Mar 31, 2025 | 597.80 Mn |
| Dec 31, 2024 | 597.70 Mn |
| Sep 30, 2024 | 597.50 Mn |
| Jun 30, 2024 | 597.30 Mn |
| Mar 31, 2024 | 597.20 Mn |
| Dec 31, 2023 | 597.00 Mn |
| Sep 30, 2023 | 596.80 Mn |
| Jun 30, 2023 | 596.70 Mn |
| Mar 31, 2023 | 596.50 Mn |
| Dec 31, 2022 | 596.30 Mn |
| Sep 30, 2022 | 596.20 Mn |
| Jun 30, 2022 | 596.00 Mn |
| Mar 31, 2022 | 595.90 Mn |
| Dec 31, 2021 | 595.70 Mn |
| Sep 30, 2021 | 595.50 Mn |